4th iPSC Drug Development and Manufacturing Summit
Evvnt Promotion / evvnt
![-](/img/icon/cal.gif)
01.10.2024 - 03.10.2024 Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 8:00 AM - 5:00 PM
Temas de la conferencia
With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of the next wave of investment.
With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of the next wave of investment.
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Observaciones
URL:
Brochure: https://go.evvnt.com/2453698-3?pid=4832
Speakers: Allen Feng, Founder and Chief Scientific Officer, HebeCell, and more
URL:
Brochure: https://go.evvnt.com/2453698-3?pid=4832
Speakers: Allen Feng, Founder and Chief Scientific Officer, HebeCell, and more
Información e inscripción:
https://go.evvnt.com/2453698-2?pid=4832
Mr. Elliot Karmel
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."